Prolactin and human breast cancer.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D001859:Bone Neoplasms; D001943:Breast Neoplasms / Q000188:drug therapy / Q000276:immunology / Q000378:metabolism* / Q000628:therapy; D002369:Castration; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004967:Estrogens; D005260:Female; D006801:Humans; D009362:Neoplasm Metastasis; D010053:Ovary / Q000601:surgery; D010146:Pain; D010640:Phenothiazines; D011388:Prolactin / Q000097:blood / Q000378:metabolism; D011956:Receptors, Cell Surface; D012636:Secretory Rate
D014150:Antipsychotic Agents; D004967:Estrogens; D010640:Phenothiazines; D011956:Receptors, Cell Surface; D004295:Dihydroxyphenylalanine; D011388:Prolactin